IVECO GROUP NV (IVG.MI) Stock Fundamental Analysis
BIT:IVG - Euronext Milan - NL0015000LU4 - Common Stock - Currency: EUR
Taking everything into account, IVG scores 5 out of 10 in our fundamental rating. IVG was compared to 106 industry peers in the Machinery industry. IVG has a medium profitability rating, but doesn't score so well on its financial health evaluation. A decent growth rate in combination with a cheap valuation! Better keep an eye on IVG.
1. Profitability
1.1 Basic Checks
In the past year IVG was profitable.
In the past year IVG had a positive cash flow from operations.
IVG had positive earnings in 4 of the past 5 years.
Each year in the past 5 years IVG had a positive operating cash flow.
1.2 Ratios
IVG has a Return On Assets of 1.73%. This is comparable to the rest of the industry: IVG outperforms 40.57% of its industry peers.
Looking at the Return On Equity, with a value of 12.39%, IVG is in the better half of the industry, outperforming 73.58% of the companies in the same industry.
The Return On Invested Capital of IVG (4.53%) is comparable to the rest of the industry.
IVG had an Average Return On Invested Capital over the past 3 years of 3.91%. This is significantly below the industry average of 9.04%.
The last Return On Invested Capital (4.53%) for IVG is above the 3 year average (3.91%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.73% | ||
| ROE | 12.39% | ||
| ROIC | 4.53% |
ROA(3y)1.3%
ROA(5y)0.32%
ROE(3y)9.48%
ROE(5y)2.54%
ROIC(3y)3.91%
ROIC(5y)N/A
1.3 Margins
With a Profit Margin value of 2.17%, IVG perfoms like the industry average, outperforming 42.45% of the companies in the same industry.
IVG's Profit Margin has improved in the last couple of years.
IVG has a Operating Margin (5.00%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of IVG has grown nicely.
IVG has a worse Gross Margin (16.49%) than 88.68% of its industry peers.
In the last couple of years the Gross Margin of IVG has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5% | ||
| PM (TTM) | 2.17% | ||
| GM | 16.49% |
OM growth 3Y29.77%
OM growth 5Y9.99%
PM growth 3Y77.09%
PM growth 5Y26.56%
GM growth 3Y7.43%
GM growth 5Y4.66%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IVG is destroying value.
Compared to 1 year ago, IVG has less shares outstanding
Compared to 5 years ago, IVG has more shares outstanding
IVG has a better debt/assets ratio than last year.
2.2 Solvency
IVG has an Altman-Z score of 1.76. This is a bad value and indicates that IVG is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.76, IVG is doing worse than 61.32% of the companies in the same industry.
The Debt to FCF ratio of IVG is 14.82, which is on the high side as it means it would take IVG, 14.82 years of fcf income to pay off all of its debts.
IVG's Debt to FCF ratio of 14.82 is on the low side compared to the rest of the industry. IVG is outperformed by 67.92% of its industry peers.
A Debt/Equity ratio of 1.35 is on the high side and indicates that IVG has dependencies on debt financing.
IVG's Debt to Equity ratio of 1.35 is on the low side compared to the rest of the industry. IVG is outperformed by 85.85% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.35 | ||
| Debt/FCF | 14.82 | ||
| Altman-Z | 1.76 |
ROIC/WACC0.65
WACC6.93%
2.3 Liquidity
IVG has a Current Ratio of 1.98. This is a normal value and indicates that IVG is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.98, IVG is in the better half of the industry, outperforming 74.53% of the companies in the same industry.
IVG has a Quick Ratio of 1.40. This is a normal value and indicates that IVG is financially healthy and should not expect problems in meeting its short term obligations.
IVG's Quick ratio of 1.40 is fine compared to the rest of the industry. IVG outperforms 78.30% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.98 | ||
| Quick Ratio | 1.4 |
3. Growth
3.1 Past
The earnings per share for IVG have decreased by -5.95% in the last year.
Measured over the past years, IVG shows a very strong growth in Earnings Per Share. The EPS has been growing by 32.82% on average per year.
The Revenue has decreased by -6.97% in the past year.
IVG shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.06% yearly.
EPS 1Y (TTM)-5.95%
EPS 3Y88.31%
EPS 5Y32.82%
EPS Q2Q%-38.1%
Revenue 1Y (TTM)-6.97%
Revenue growth 3Y6.52%
Revenue growth 5Y5.06%
Sales Q2Q%-3.52%
3.2 Future
Based on estimates for the next years, IVG will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.81% on average per year.
The Revenue is expected to grow by 3.89% on average over the next years.
EPS Next Y-3.69%
EPS Next 2Y7.38%
EPS Next 3Y10.65%
EPS Next 5Y10.81%
Revenue Next Year-1.8%
Revenue Next 2Y2.45%
Revenue Next 3Y3.63%
Revenue Next 5Y3.89%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
IVG is valuated reasonably with a Price/Earnings ratio of 11.59.
Based on the Price/Earnings ratio, IVG is valued cheaper than 81.13% of the companies in the same industry.
IVG's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.86.
The Price/Forward Earnings ratio is 7.63, which indicates a rather cheap valuation of IVG.
Based on the Price/Forward Earnings ratio, IVG is valued cheaply inside the industry as 87.74% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 34.94, IVG is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.59 | ||
| Fwd PE | 7.63 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, IVG is valued cheaply inside the industry as 81.13% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, IVG is valued a bit cheaper than 73.58% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.42 | ||
| EV/EBITDA | 5.48 |
4.3 Compensation for Growth
IVG has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.35
EPS Next 2Y7.38%
EPS Next 3Y10.65%
5. Dividend
5.1 Amount
IVG has a Yearly Dividend Yield of 1.80%.
IVG's Dividend Yield is comparable with the industry average which is at 2.82.
IVG's Dividend Yield is slightly below the S&P500 average, which is at 2.36.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.8% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
27.33% of the earnings are spent on dividend by IVG. This is a low number and sustainable payout ratio.
DP27.33%
EPS Next 2Y7.38%
EPS Next 3Y10.65%
BIT:IVG (8/21/2025, 2:44:16 PM)
18.31
+0.04 (+0.22%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)
Earnings (Next)
Inst Owners41.97%
Inst Owner ChangeN/A
Ins Owners0.1%
Ins Owner ChangeN/A
Market Cap4.97B
Analysts73.85
Price Target19.97 (9.07%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.8% |
Yearly Dividend0.27
Dividend Growth(5Y)N/A
DP27.33%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.8%
Min EPS beat(2)-15.44%
Max EPS beat(2)5.84%
EPS beat(4)3
Avg EPS beat(4)15.3%
Min EPS beat(4)-15.44%
Max EPS beat(4)63.53%
EPS beat(8)5
Avg EPS beat(8)15.63%
EPS beat(12)8
Avg EPS beat(12)16.7%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.77%
Min Revenue beat(2)-10.1%
Max Revenue beat(2)8.56%
Revenue beat(4)3
Avg Revenue beat(4)2.17%
Min Revenue beat(4)-10.1%
Max Revenue beat(4)9.28%
Revenue beat(8)5
Avg Revenue beat(8)0.74%
Revenue beat(12)7
Avg Revenue beat(12)2.33%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)9.3%
PT rev (3m)20.26%
EPS NQ rev (1m)-17.7%
EPS NQ rev (3m)-1.06%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-3.67%
Revenue NQ rev (3m)-4.95%
Revenue NY rev (1m)-1.81%
Revenue NY rev (3m)-1.81%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.59 | ||
| Fwd PE | 7.63 | ||
| P/S | 0.34 | ||
| P/FCF | 12.42 | ||
| P/OCF | 3.85 | ||
| P/B | 1.91 | ||
| P/tB | 9 | ||
| EV/EBITDA | 5.48 |
EPS(TTM)1.58
EY8.63%
EPS(NY)2.4
Fwd EY13.1%
FCF(TTM)1.47
FCFY8.05%
OCF(TTM)4.75
OCFY25.96%
SpS54.61
BVpS9.58
TBVpS2.04
PEG (NY)N/A
PEG (5Y)0.35
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.73% | ||
| ROE | 12.39% | ||
| ROCE | 6% | ||
| ROIC | 4.53% | ||
| ROICexc | 5.79% | ||
| ROICexgc | 7.34% | ||
| OM | 5% | ||
| PM (TTM) | 2.17% | ||
| GM | 16.49% | ||
| FCFM | 2.7% |
ROA(3y)1.3%
ROA(5y)0.32%
ROE(3y)9.48%
ROE(5y)2.54%
ROIC(3y)3.91%
ROIC(5y)N/A
ROICexc(3y)4.85%
ROICexc(5y)N/A
ROICexgc(3y)5.77%
ROICexgc(5y)N/A
ROCE(3y)5.17%
ROCE(5y)N/A
ROICexcg growth 3Y26.65%
ROICexcg growth 5Y12.05%
ROICexc growth 3Y25.45%
ROICexc growth 5Y11.07%
OM growth 3Y29.77%
OM growth 5Y9.99%
PM growth 3Y77.09%
PM growth 5Y26.56%
GM growth 3Y7.43%
GM growth 5Y4.66%
F-Score6
Asset Turnover0.8
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.35 | ||
| Debt/FCF | 14.82 | ||
| Debt/EBITDA | 2.37 | ||
| Cap/Depr | 119.97% | ||
| Cap/Sales | 6% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 86.98% | ||
| Profit Quality | 124.22% | ||
| Current Ratio | 1.98 | ||
| Quick Ratio | 1.4 | ||
| Altman-Z | 1.76 |
F-Score6
WACC6.93%
ROIC/WACC0.65
Cap/Depr(3y)146.94%
Cap/Depr(5y)121.88%
Cap/Sales(3y)5.9%
Cap/Sales(5y)5.2%
Profit Quality(3y)212.1%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.95%
EPS 3Y88.31%
EPS 5Y32.82%
EPS Q2Q%-38.1%
EPS Next Y-3.69%
EPS Next 2Y7.38%
EPS Next 3Y10.65%
EPS Next 5Y10.81%
Revenue 1Y (TTM)-6.97%
Revenue growth 3Y6.52%
Revenue growth 5Y5.06%
Sales Q2Q%-3.52%
Revenue Next Year-1.8%
Revenue Next 2Y2.45%
Revenue Next 3Y3.63%
Revenue Next 5Y3.89%
EBIT growth 1Y-21.25%
EBIT growth 3Y38.23%
EBIT growth 5Y15.55%
EBIT Next Year76.38%
EBIT Next 3Y30.18%
EBIT Next 5YN/A
FCF growth 1Y-7.83%
FCF growth 3YN/A
FCF growth 5Y-8.52%
OCF growth 1Y-0.31%
OCF growth 3Y26.42%
OCF growth 5Y8.96%